✦ LIBER ✦

Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma

✍ Scribed by Ewa Joanna Majdak; Jaroslaw Debniak; Tomasz Milczek; Cees J. Cornelisse; Peter Devilee; Janusz Emerich; Jacek Jassem; Geertruida Hendrika De Bock

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 213 KB
Volume: 104
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21276

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BRCA1 and BRCA2 mutations in breast/ovar

BRCA1 and BRCA2 mutations in breast/ovarian cancer patients from central Italy

✍ L. Stuppia; P. Di Fulvio; G. Aceto; S. Pintor; S. Veschi; V. Gatta; A. Colosimo; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

We report on the screening of the entire BRCA1/BRCA2 coding sequence by SSCP, PTT, and direct sequencing in 68 Italian families with recurrent breast or ovarian cancer. For each investigated proband, the probability of being carrier of a BRCA1/BRCA2 mutation was evaluated using the BRCAPRO software.

Prevalence of BRCA1 and BRCA2 mutations

Prevalence of BRCA1 and BRCA2 mutations in Pakistani breast and ovarian cancer patients

✍ Muhammad U. Rashid; Anbreen Zaidi; Diana Torres; Faisal Sultan; Axel Benner; Bil 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 312 KB 👁 1 views

## Abstract Among Asian countries, Pakistan has the highest rates of breast and ovarian cancer. To assess the contribution of the __BRCA1__ and __BRCA2__ germ line mutations to these high rates, we conducted the first study of 176 Pakistani breast and ovarian cancer patients, selected on family his

RNA analysis of eight BRCA1 and BRCA2 un

RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain

✍ Berta Campos; Orland Díez; Montserrat Domènech; Manel Baena; Judith Balmaña; Jud 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

Germ-line mutations in the breast cancer susceptibility genes BRCA1 and BRCA2 account for a large proportion of hereditary breast/ovarian cancer families. A large number of disease-causing germ-line mutations and variants of unknown pathological significance have been identified in both genes. The m

BRCA1 and BRCA2 mutations account for a

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

✍ Tuya Pal; Jenny Permuth-Wey; Judith A. Betts; Jeffrey P. Krischer; James Fiorica 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Germline mutations in the BRCA1 and BRCA

Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients

✍ A. Esra Manguoǧlu; Güven Lüleci; Tayfun Özçelik; Taner Çolak; Hagit Schayek; Mus 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 1 views

In this study we genotyped Turkish breast/ovarian cancer patients for BRCA1/BRCA2 mutations: protein truncation test (PTT) for exon 11 BRCA1 of and, multiplex PCR and denaturing gradient gel electrophoresis (DGGE) for BRCA2, complemented by DNA sequencing. In addition, a modified restriction assay w

Recurrent BRCA1 and BRCA2 germline mutat

Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: A founder mutation of BRCA1 identified in the Chinese population

✍ Ui-Soon Khoo; Kelvin Y.K. Chan; Annie N.Y. Cheung; W.C. Xue; D.H. Shen; K.Y. Fun 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 1 views

Previous mutational analysis for BRCA gene mutations in sporadic ovarian cancer occurring in Chinese patients in Hong Kong identified six germline BRCA1 mutations and one germline BRCA2 mutation, six of which were novel (Khoo et al., 2000). Knowledge of BRCA gene mutations in the Chinese population